SMSofie Mylle

Sofie Mylle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sofie Mylle has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study

    by Sofie Mylle, Jorien Papeleu, Isabelle Hoorens, Evelien Verhaeghe, Lieve Brochez


  • Dermatologist versus artificial intelligence confidence in dermoscopy diagnosis: Complementary information that may affect decision‐making

    by Pieter Van Molle, Sofie Mylle, Tim Verbelen, Cedric De Boom, Bert Vankeirsbilck, Evelien Verhaeghe, Bart Dhoedt, Lieve Brochez

    In dermatology, deep learning may be applied for skin lesion classification. However, for a given input image, a neural network only outputs a label, obtained using the class probabilities, which do not model uncertainty. Our group developed a novel method to quantify uncertainty in stochastic neural networks. In this study, we aimed to train such network for skin lesion classification and evaluate its diagnostic performance and uncertainty, and compare the results to the assessments by a group of dermatologists. By passing duplicates of an image through such a stochastic neural network, we obtained distributions per class, rather than a single probability value. We interpreted the overlap between these distributions as the output uncertainty, where a high overlap indicated a high uncertainty, and vice versa. We had 29 dermatologists diagnose a series of skin lesions and rate their confidence. We compared these results to those of the network. The network achieved a sensitivity and specificity of 50% and 88%, comparable to the average dermatologist (respectively 68% and 73%). Higher confidence/less uncertainty was associated with better diagnostic performance both in the neural network and in dermatologists. We found no correlation between the uncertainty of the neural network and the confidence of dermatologists (R = −0.06, p = 0.77). Dermatologists should not blindly trust the output of a neural network, especially when its uncertainty is high. The addition of an uncertainty score may stimulate the human‐computer interaction.


  • Open Access

    The Value of Teledermatology Advice for Skin Toxicity in Oncology: Experience From a Pilot Study (Preprint)

    by Sofie Mylle, Jorien Papeleu, Isabelle Hoorens, Evelien Verhaeghe, Lieve Brochez

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Despite skin toxicity during anti-EGFR therapy occurs frequently and significantly impacts patients’ quality of life, it is often not recognized nor optimally managed. This may lead to unnecessary dose reductions or treatment discontinuations of the cancer treatment. Access to rapid dermatology advice may be limited in hospitals. In this multicenter pilot study, we conclude that teledermatology may add value for both patients and oncologists in the management of treatment-induced skin toxicity.